Product Overview

Sitagliptin phosphate monohydrate is a core active pharmaceutical ingredient (API) for dipeptidyl peptidase-4 (DPP-4) inhibitors in antidiabetic drugs. It is widely used in the research and development and production of oral hypoglycemic drugs and is suitable for the entire lifecycle of production, from laboratory research and development and small-scale trials to pilot-scale and industrial-scale production. It has high purity, stability and good process compatibility, meeting the high standards of the pharmaceutical industry for API quality and supply.

Applications

• Synthesis of active pharmaceutical ingredients (APIs) for diabetes treatment
• Preparation of intermediates for antidiabetic drugs
• Development and optimization of drug formulation processes
• API procurement and supply chain management for pharmaceutical companies
• Key starting materials in innovative drug development

Quality & Supply Capability

English Name: Sitagliptin phosphate monohydrate Properties: White crystalline powder, readily soluble in water, with good thermal and chemical stability. Contains a phosphate structure, suitable for various synthetic routes and formulation processes. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from sample supply, small-scale preparation, pilot-scale amplification to customized batch production. We can flexibly adjust the supply plan according to customer requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. We also provide technical support from laboratory R&D to scale-up production, helping customers advance process development, route optimization, and project transformation, ensuring an efficient, compliant, and stable supply of active pharmaceutical ingredients.

Why Choose Bioncan

Focused on active pharmaceutical ingredients (APIs), with extensive experience supplying DPP-4 inhibitor compounds. Full-scale supply capabilities, covering all stages from laboratory to commercial production. Comprehensive quality control documentation support, including COA, MSDS, HPLC, NMR, etc. Customized supply to meet diverse application scenarios. Supporting process optimization technologies to facilitate a smooth transition from R&D to mass production.

Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 654671-77-9, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.